One of the largest NSCLC series that was treated with anti-PD1/anti-PD-L1 therapy and different modalities of radiation (SRS, WBRT, partial brain radiation) proved this combination to be safe and effective [82]. Here, CD274 is linked to non-small cell lung carcinoma.